Piperacillin-Associated Immune Thrombocytopenia
- PMID: 37713713
- DOI: 10.1097/MJT.0000000000001521
Piperacillin-Associated Immune Thrombocytopenia
Conflict of interest statement
The authors have no conflicts of interest to declare.
References
-
- Moreau D, Timsit JF, Vesin A, et al. Platelet count decline: an early prognostic marker in critically ill patients with prolonged ICU stays. Chest. 2007;131:1735–1741.
-
- Aster RH, Curtis BR, McFarland JG, et al. Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost. 2009;7:911–918.
-
- Sullivan K, Kaminer LS, Grinblatt DL, et al. Trastuzumab-induced thrombocytopenia correlated by drug-dependent platelet antibodies. JCO Oncol Pract. 2021;17:153–155.
-
- Arnold DM, Nazi I, Warkentin TE, et al. Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Transfus Med Rev. 2013;27:137–145.
-
- Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–245.